Showing results (61-70 of 10,058) with videos related to
Sort By:
Pageof 1,006
Current Pharmaceutical Design|August 12, 2010
Glycogen synthase kinase-3 (GSK-3) inhibitors for the treatment of Alzheimer's diseaseMiguel Medina, Jesús AvilaCurrent Pharmaceutical Design|March 12, 2011
Pharmacological activation of p53 in cancer cellsMohammad Athar, Craig A Elmets, Levy KopelovichCurrent Pharmaceutical Design|March 12, 2011
Small-molecule inhibitors of p53-MDM2 interaction: the 2006-2010 updateMelissa Millard, Divya Pathania, Fedora Grande, et al.Current Pharmaceutical Design|April 16, 2011
Food addiction and neuroimagingYi Zhang, Karen M von Deneen, Jie Tian, et al.Current Pharmaceutical Design|April 16, 2011
Should overeating and obesity be classified as an addictive disorder in DSM-5?Claudia Moreno, Rajiv TandonCurrent Pharmaceutical Design|March 23, 2011
Lipid management for the prevention of cardiovascular diseaseJuergen R SchaeferCurrent Pharmaceutical Design|March 23, 2011
Cardiovascular disease and dyslipidemia: beyond LDLJanine Pöss, Florian Custodis, Christian Werner, et al.Current Pharmaceutical Design|March 23, 2011
The role of vitamin D in dyslipidemia and cardiovascular diseaseArmin Zittermann, Jan F Gummert, Jochen BörgermannCurrent Pharmaceutical Design|April 8, 2011
Microbial efflux pump inhibition: tactics and strategiesGeorge P Tegos, Mark Haynes, J Jacob Strouse, et al.Current Pharmaceutical Design|April 8, 2011
Humanized SCID mice models of SLENikola Kerekov, Nikolina Mihaylova, Jozsef Prechl, et al.Pageof 1,006